N-[(1,3-benzothiazol-2-yl)(phenyl)methyl]prop-2-enamide
Structure Info
- Chemspace ID
- CSSB00697456304 (In-Stock Building Blocks)
- IUPAC Name
- N-[(1,3-benzothiazol-2-yl)(phenyl)methyl]prop-2-enamide
- Mol formula
- C17H14N2OS
- Mol weight
- 294 Da
- Catalog Number(s)
- BBLS00697456304, CSCR00697456304, EN300-45757642, Z3325092362, bbls00697456304
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 3.82
- Heavy atoms count
- 21
- Rotatable bond count
- 4
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.058
- Polar surface area (Å)
- 42
- Hydrogen bond acceptors count
- 2
- Hydrogen bond donors count
- 1
![Chemical structure of N-[(1,3-benzothiazol-2-yl)(phenyl)methyl]prop-2-enamide (C17H14N2OS) - CSSB00697456304](/st/structure/200/fd4d722a011e07f19d44cb817aac927c/C%253DCC%2528%253DO%2529NC%2528C1%253DNC2%253DCC%253DCC%253DC2S1%2529C1%253DCC%253DCC%253DC1.png "C17H14N2OS")
- Zoom the structure
- CSSB00697456304
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 515.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 539.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 564.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 589.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 614.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 1,202.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,779.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 2,638.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of N-[1-(1,3-benzothiazol-2-yl)ethyl]prop-2-enamide - CSSB01993917631](/st/structure/200/2a4614a8d5617365027016225fbe3a6a/C%253DCC%2528%253DO%2529NC%2528C%2529C1%253DNC2%253DCC%253DCC%253DC2S1.png)
![Chemical structure of N-[(4-methyl-1,3-thiazol-2-yl)(phenyl)methyl]prop-2-enamide - CSSB21332069826](/st/structure/200/316afd525de6052edbdd93354ba5a25c/CC1%253DCSC%2528%253DN1%2529C%2528NC%2528%253DO%2529C%253DC%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-[(1,3-benzothiazol-2-yl)(phenyl)methyl]-2-chloroacetamide - CSSB01777105212](/st/structure/200/bdfa84df7a1163bc0a9984ce757541aa/ClCC%2528%253DO%2529NC%2528C1%253DNC2%253DCC%253DCC%253DC2S1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-[(1,3-benzothiazol-2-yl)(phenyl)methyl]-2-chloro-2-fluoroacetamide - CSSB21332052682](/st/structure/200/87a7b6433847920d0dc248df67cd30d9/FC%2528Cl%2529C%2528%253DO%2529NC%2528C1%253DNC2%253DC%2528S1%2529C%253DCC%253DC2%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-[1-(1,3-benzothiazol-2-yl)propan-2-yl]prop-2-enamide - CSSB01997578798](/st/structure/200/e8a9ea7eda648b2191ad32dfe619b874/C%253DCC%2528%253DO%2529NC%2528C%2529CC1%253DNC2%253DCC%253DCC%253DC2S1.png)
![Chemical structure of N-[(1,3-benzothiazol-2-yl)(phenyl)methyl]ethene-1-sulfonamide - CSSB21332125749](/st/structure/200/6fa2a0e59675ae7a8ea242ee6788873a/C%253DCS%2528%253DO%2529%2528%253DO%2529NC%2528C1%253DNC2%253DC%2528S1%2529C%253DCC%253DC2%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-[(5-methyl-1,2,4-oxadiazol-3-yl)(phenyl)methyl]prop-2-enamide - CSSB00138552122](/st/structure/200/d9820efe58f0ceca22028501b71296c7/CC1%253DNC%2528%253DNO1%2529C%2528NC%2528%253DO%2529C%253DC%2529C1%253DCC%253DCC%253DC1.png)
